Phase 4 ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children who have been diagnosed with ADHD, in any form
- Children whose ADHD causes moderate or significant difficulties in daily life
- Children who show higher-than-usual levels of irritability and/or aggression, as rated by a parent or guardian using specific assessment tools
- Both the child and their parent or guardian are fluent in English
- The parent or guardian is willing for the child to take stimulant medication (a common type of ADHD medication) as part of the trial
Who may not be able to join:
- Children who have a medical reason that makes stimulant medication unsafe for them
- Children who have a diagnosis of Autism Spectrum Disorder
- Children who have a diagnosis of Bipolar Disorder
- Children who have an intellectual or developmental disability
- Children who are currently taking antipsychotic or mood-stabilising medications
- Children who are taking other medications that could interfere with brainwave (EEG) recording, such as benzodiazepines
- Children who have hearing or vision difficulties that would make it hard to complete computer-based tasks
- Children who are currently experiencing a major depressive episode
- Children who are currently having thoughts of suicide
- Children who have already tried and not responded to two full courses of methylphenidate-based medications AND two full courses of amphetamine-based medications
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-800-243-1455
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
RCT phase: Guardian rated Affective reactivity Index (ARI); Open label dose opt: ADHD RS 5 clinician interview; RCT phase abridged Revised modified overt aggression scale (RMOAS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.